Evaluation of GLR2007 for Advanced Solid Tumors

NCT04444427 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer
Glioblastoma Multiforme

Interventions

DRUG: GLR2007

Sponsor

Gan and Lee Pharmaceuticals, USA